BHVN
BRL (BHVN)
NYSE
$15.09-$0.41 (-2.65%)
Price as of Jun 23, 2026 6:39 PM EDT
  • $1.2B
    Market Cap
  • 7.19%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-635.1M
-20.21%
-795.9M
+113.21%
-373.3M
-14.60%
-437.1M
N/A
Depreciation and Amortization Expense
9.9M
+26.31%
7.9M
+13.64%
6.9M
+398.70%
1.4M
N/A
Total Operating Expenses
745.4M
-15.79%
885.1M
+102.98%
436.1M
-23.22%
567.9M
N/A
Operating Profit
-745.4M
-15.79%
-885.1M
+102.98%
-436.1M
-23.22%
-567.9M
N/A
Interest Income
5.1M
-27.75%
7.0M
-5.36%
7.4M
+129.74%
3.2M
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
5.1M
-27.75%
7.0M
-5.36%
7.4M
+129.74%
3.2M
N/A
Total Nonoperating Income and Expense
8.0M
-79.71%
39.4M
+48.77%
26.5M
+1,488.16%
-1.9M
N/A
Income before Taxes
-737.4M
-12.81%
-845.7M
+106.49%
-409.6M
-28.13%
-569.8M
N/A
Income Taxes
1.4M
+96.19%
735,000
+153.15%
-1.4M
-415.75%
438,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-738.8M
-12.71%
-846.4M
+107.37%
-408.2M
-28.43%
-570.3M
N/A
Net Income from Continuing Operations Applicable to Common
-737.4M
-12.81%
-845.7M
+106.49%
-409.6M
-28.13%
-569.8M
N/A
Basic EPS and Net Income
-6.86
-26.08%
-9.28
+61.95%
-5.73
-55.06%
-12.75
N/A
Diluted EPS and Net Income
-6.86
-26.08%
-9.28
+61.95%
-5.73
-55.06%
-12.75
N/A
Basic Weighted Average Shares
107.6M
+17.97%
91.2M
+28.14%
71.2M
+59.14%
44.7M
N/A
Diluted Weighted Average Shares
107.6M
+17.97%
91.2M
+28.14%
71.2M
+59.14%
44.7M
N/A
Balance Sheet
Cash and Cash Equivalents
230.0M
+131.97%
99.1M
-60.09%
248.4M
+21.24%
204.9M
N/A
Short-Term Investments
89.2M
-76.95%
386.9M
+189.96%
133.4M
-48.78%
260.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
319.1M
-34.33%
486.0M
+27.28%
381.8M
-17.95%
465.3M
N/A
Total Current Assets
368.3M
-31.60%
538.5M
+21.70%
442.4M
-24.62%
587.0M
N/A
Accumulated Depreciation
16.1M
+32.12%
12.2M
+47.36%
8.3M
+68.56%
4.9M
N/A
Property and Plant and Equipment and Net
16.0M
-7.83%
17.3M
+0.75%
17.2M
-1.83%
17.5M
N/A
Total Long-Term Assets
47.4M
+19.83%
39.5M
+16.99%
33.8M
-9.94%
37.5M
N/A
Total Assets
451.4M
-26.61%
615.1M
+19.85%
513.2M
-22.45%
661.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
115.9M
-24.83%
154.2M
+178.27%
55.4M
-38.43%
90.0M
N/A
Total Long-Term Debt
238.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
4.6M
-1.72%
4.7M
+107.71%
2.2M
-6.85%
2.4M
N/A
Total Liabilities
399.4M
+108.36%
191.7M
+124.87%
85.2M
-30.71%
123.0M
N/A
Retained Earnings
-2.1B
+54.90%
-1.3B
+169.52%
-499.3M
+447.93%
-91.1M
N/A
Total Stockholders Equity
52.1M
-87.70%
423.4M
-1.06%
428.0M
-20.56%
538.8M
N/A
Total Shares Outstanding
132.8M
+31.17%
101.2M
+24.79%
81.1M
+18.95%
68.2M
N/A
Cash Flow
Cash from Operating Activities
-609.4M
+4.63%
-582.5M
+75.58%
-331.7M
+11.43%
-297.7M
N/A
Capital Expenditures
715,000
-82.34%
4.0M
+32.84%
3.0M
-49.82%
6.1M
N/A
Cash from Investing Activities
300.6M
+222.69%
-245.0M
-288.69%
129.8M
+142.60%
-304.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
439.1M
-35.21%
677.8M
+219.84%
211.9M
-72.39%
767.6M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-138.54%
-7.66%
-150.03%
+115.95%
-69.48%
N/A
N/A
N/A
Return on Equity
-310.75%
+56.29%
-198.83%
+135.46%
-84.44%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.18
-9.00%
3.49
-56.27%
7.98
N/A
N/A
N/A
Cash Ratio
1.98
+208.57%
0.64
-85.66%
4.48
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow